Infinant Health, .

Infinant Health, .Infinant Health, .
IH

Infinant Health, .

Changing the trajectory of human health, one baby at a time.

Website
DR 352021ActiveBoston, United States
Rate
Advertise here

About

Infinant Health's mission is to change the trajectory of human health, one baby at a time, by unlocking the potential of the infant gut microbiome. Their products, in combination with breast milk, aim to build a foundation for better health in infants. They have developed INF108, a drug strain designed to prevent Necrotizing Enterocolitis (NEC) in premature infants, based on their research into the role of B. infantis.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Infinant Health, . do?

Infinant Health's mission is to change the trajectory of human health, one baby at a time, by unlocking the potential of the infant gut microbiome. Their products, in combination with breast milk, aim to build a foundation for better health in infants. They have developed INF108, a drug strain designed to prevent Necrotizing Enterocolitis (NEC) in premature infants, based on their research into the role of B. infantis.

How much funding has Infinant Health, . raised?

Infinant Health, . has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Infinant Health, . headquartered?

Infinant Health, . is headquartered in Boston, United States.

When was Infinant Health, . founded?

Infinant Health, . was founded in 2021.

What industry does Infinant Health, . operate in?

Infinant Health, . operates in HealthTech, MedTech, Digital Twin Healthcare, Genomics, Clinical Trials, AI-Driven Drug Discovery.

What is Infinant Health, .'s revenue?

StartupHub estimates Infinant Health, .'s annual revenue at $1.2M (range $667K to $2.3M, 28% confidence), based on comparable companies in the sector.

What is Infinant Health, .'s valuation?

StartupHub estimates Infinant Health, .'s effective valuation at $38.6M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.